InsiderInsights.com Daily Ratings Report: October 5, 2023
InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research processProvident Bancorp is a bank holding company. Through its subsidiary, The Provident Bank, the company operates as a community bank. The company's lending activities include the provision of commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one- to four-family residential loans, home equity loans and lines of credit, and consumer loans. The company also accepts deposits through the provision of deposit instruments, including noninterest-bearing demand deposits (such as checking accounts), interest-bearing demand accounts (such as Negotiable Order of Withdrawal and money market accounts), and certificates of deposit.
Red Robin Gourmet Burgers, together with its subsidiaries, primarily develops, operates, and franchises restaurants in North America and focuses on serving gourmet burgers. The company's menu features its product, a line of Gourmet Burgers. To complement its Gourmet Burgers Co. provides a line of Red's Tavern Double? burgers. In addition to burgers, the company serves an array of other items. These items include a variety of appetizers, salads, soups, seafood, and other entrees. The company also provides a range of single-serving and shareable desserts as well as its Finest milkshakes. The company's beverages include alcoholic and non-alcoholic specialty drinks, cocktails, wine, and a variety of national and craft beers.
Vaccinex is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. The company is engaged in the field of semaphorin 4D (SEMA4D) biology, targeting SEMA4D as a potential treatment for cancer, neurodegenerative diseases, or autoimmune disorders. The company is utilizing its SEMA4D antibody platform to develop its primary product candidate, pepinemab (VX15/2503), an antibody that utilizes mechanisms of action. The company is focused on the development of pepinemab for the treatment of non-small cell lung cancer, Huntington's disease, and Alzheimer's disease.
Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.
Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.
InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.